Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 41, Issue 3, 1998, Pages 421-426

  Song, Yeong Wook ^a,c   Han, Chang Wan ^a   Kang, Seong Wook ^a   Baek, Han Joo ^a   Lee, Eun Bong ^a   Shin, Chang H O ^a   Hahn, Bevra H ^b   Tsao, Betty P ^b  

^a Seoul National University Hospital   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR;

ADULT; AGED; ALLELE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DRUG RECEPTOR BINDING; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; KOREA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE DISTRIBUTION;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; KOREA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; POLYMORPHISM, GENETIC; RECEPTORS, FC; REFERENCE VALUES; RISK FACTORS;

EID: 0000220519     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199803)41:3<421::AID-ART7>3.0.CO;2-S     Document Type: Article

References (19)

1. Van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993;14:215-21.
2. Salmon JE, Edberg JC, Kimberly RP. Fcγ receptor III on human neutrophils: allelic variants have functionally distinct capacities. J Clin Invest 1990;85:1287-95.
3. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphism of human Fcγ receptor IIA and Fcγ receptor IIIB: independent mechanisms for differences in human phagocytic function. J Clin Invest 1992;89:1274-81.
4. Warmerdam PAM, van de Winkel JGJ, Gosselin EJ, Capel PJA. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 1990;172:19-25.
5. Warmerdam PAM, van de Winkel JGJ, Vlug A, Westerdal NAC, Capel PJA. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991;147:1338-43.
6. Clark MR, Stuart SG, Kimberly RP, Ory OA, Goldstein LM. A single amino acid distinguishes the high-responder from low-responder for Fc receptor II on human monocytes. Eur J Immunol 1991;21:1911-6.
7. Tate BJ, Witort E, McKenzie IFC, Hogarth PM. Expression of the high-responder/non-responder human FcγRIIa: analysis by PCR and transfection into FcR-COS cells. Immunol Cell Biol 1992;70: 79-87.
8. Parren PWHI, Warmerdam PAM, Boeije LCM, Arts J, Westerdaal NAC. Vlug A, et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils and platelets: analysis of a functional polymorphism to human IgG2. J Clin Invest 1992;90:1537-46.
9. Anderson CL, Shen L, Eicher DM, Wewers MD, Gill JK. Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes. J Exp Med 1990;171:1333-45.
10. Indik Z, Kelly C, Chien P, Levinson AI, Schreiber AD. Human FcγRII, in the absence of other Fcy receptors, mediates a phagocytic signal. J Clin Invest 1991;88:1766-71.
11. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;39:1832-6.
12. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. FcγRIIa alleles are heritable risk factors for lupus nephritis in American Africans. J Clin Invest 1996;97:1348-54.
13. Botto M, Theodoridis E, Thompson EM, Beynon HLC, Briggs D, Isenberg DA, et al. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 1996;104:264-8.
14. Lee HS, Spargo BH. A renal biopsy of lupus nephropathy in the United States and Korea. Am J Kidney Dis 1985;5:242-50.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
17. Osborne JM, Chacko GW, Brandt JT, Anderson CL. Ethnic variation in frequency of an allelic polymorphism of human FcyRIIa determined with allele specific oligonucleotide probes. J Immunol Methods 1994;173:207-17.
18. Anderson CL, Ryan DH, Looney RJ, Leary PC. Structural polymorphism of the human monocyte 40 kilodalton Fc receptor for IgG. J Immunol 1987;138:2254-6.
19. Schachter LA, Wisnieski JJ, Denburg MR, Michael AR, Ginzler EM, Gourley MF, et al. Antibodies to the collagen-like region of C1q in systemic lupus erythematosus: likely contributors to renal disease [abstract]. Arthritis Rheum 1996;39 Suppl 9:S252.